Cd38 Mouse Models
| Field | Value |
|---|---|
| Mouse symbol | Cd38 |
| Human ortholog | CD38 |
| Aliases | T10, ADPRC1 |
| Protein class | Cell-surface ectoenzyme / glycoprotein (ADP-ribosyl cyclase) |
| Location (human) | 4p15.32 |
| Mouse gene (MGI) | MGI:107474 |
| Human gene | HGNC:1667 · NCBI Gene 952 |
Why Model Cd38
Cd38 is the mouse ortholog of human CD38 and encodes CD38, a cell-surface glycoprotein with ectoenzyme activity involved in the metabolism of NAD+ and cyclic ADP-ribose. CD38 is expressed on plasma cells and various immune cells and has been associated with roles in calcium signaling and cell adhesion.
CD38 is highly expressed on malignant plasma cells in multiple myeloma, and CD38-directed antibodies are used in that disease, often combined with other agents; responses vary. Cd38-deficient mice are viable and show altered immune and metabolic responses.
Model Applications
Humanized CD38 models, in which the human protein replaces the mouse counterpart, have been used to evaluate anti-CD38 antibodies in immunocompetent mice.
Cd38 knockout mice have been used to study NAD+ metabolism and immune regulation in defined experimental settings.
Custom Cd38 Model Options
Engineered to your specifications, with molecular validation of the targeted allele and germline transmission guaranteed.
- Conventional knockout
- Conditional knockout
- Point mutation / knockin
- Reporter knockin
- Humanized
- Targeted transgenic
Sources
- Efficacy and safety of anti-CD38 monoclonal antibodies-based therapy versus standard therapy in newly diagnosed multiple myeloma: a systematic review and meta-analysis. Ther Adv Hematol. 2025. doi:10.1177/20406207251314289
- Jackson DG, Bell JI. Isolation of a cDNA encoding the human CD38 (T10) molecule, a cell surface glycoprotein with an unusual discontinuous pattern of expression during lymphocyte differentiation. J Immunol. 1990. doi:10.4049/jimmunol.144.7.2811
Last reviewed: October 22, 2026 · Reviewed by: Paul Sheiffele
Newsletter
Stay Ahead with Lab Signals
Expert research insights delivered biweekly. Written by PhD scientists, designed for researchers who need cutting-edge knowledge to advance their projects.